In the second of our two-part series on vendor commercial due diligence (VCDD), Adam Scott,
senior partner, and Abhishek Patel, engagement manager, at Mansfield Advisors, discuss how
to effectively engage with advisors to create a compelling narrative for buyers
Private equity healthcare IT deals have slowed in 2023, but add-ons have continued to grow, say Adam Scott, senior partner and Johan Ottosson, senior associate, at Mansfield Advisors, who look at the rationale for investing in the sector.
Adam Scott and Ty Lantz of Mansfield Advisors explore some of the supply-side market forces that drive location selection and the patterns that they create in the retail pharmacy, veterinary, and private medicine sectors.
Where are the trends in the non-therapeutic antibodies market and how can investors create value?
Why your next investor may have more experience in bridges and airports than patients.
